Putting an end to hospital-borne infection with micronebulisation of lung-safe disinfectants. Dangerous infections are unfortunately common in hospitals, established and retransmitted via surfaces and handheld items, representing a leading contributor to death worldwide, and potentially a far more serious problem to come as antimicrobial resistance worsens. The project aims to exploit a newly discovered and unique low power nebulisation technology to nebulise a strongly antiviral, antibacterial ....Putting an end to hospital-borne infection with micronebulisation of lung-safe disinfectants. Dangerous infections are unfortunately common in hospitals, established and retransmitted via surfaces and handheld items, representing a leading contributor to death worldwide, and potentially a far more serious problem to come as antimicrobial resistance worsens. The project aims to exploit a newly discovered and unique low power nebulisation technology to nebulise a strongly antiviral, antibacterial and antifungal agent, triethylene glycol that is too viscous to do so by any other known method. Through refinement and engineering of the technology via this project, handheld and room-based continuously operating nebulisers will produce continuous microdroplet mists of these pathogen-killing agents that deposit on surfaces throughout a hospital.Read moreRead less